These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 22228794)

  • 1. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.
    Youssef G; Leung E; Mylonas I; Nery P; Williams K; Wisenberg G; Gulenchyn KY; Dekemp RA; Dasilva J; Birnie D; Wells GA; Beanlands RS
    J Nucl Med; 2012 Feb; 53(2):241-8. PubMed ID: 22228794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.
    Tang R; Wang JT; Wang L; Le K; Huang Y; Hickey AJ; Emmett L
    Clin Nucl Med; 2016 Jul; 41(7):e327-39. PubMed ID: 26646995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
    Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
    J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
    Adhaduk M; Paudel B; Khalid MU; Ashwath M; Mansour S; Liu K
    J Nucl Cardiol; 2023 Aug; 30(4):1574-1587. PubMed ID: 36443587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
    Aitken M; Chan MV; Urzua Fresno C; Farrell A; Islam N; McInnes MDF; Iwanochko M; Balter M; Moayedi Y; Thavendiranathan P; Metser U; Veit-Haibach P; Hanneman K
    Radiology; 2022 Sep; 304(3):566-579. PubMed ID: 35579526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
    Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
    Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic test accuracies of F-18 FDG PET for characterisation of cardiac masses compared to conventional imaging techniques: systematic review and meta-analysis.
    Kim K; Ko WS; Kim SJ
    Br J Radiol; 2022 Jul; 95(1135):20210263. PubMed ID: 35612548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.
    Ohira H; Tsujino I; Yoshinaga K
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1773-83. PubMed ID: 21559980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of quantitative assessment of cardiac
    Lebasnier A; Legallois D; Bienvenu B; Bergot E; Desmonts C; Zalcman G; Agostini D; Manrique A
    Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of FDG-PET versus magnetic resonance imaging for detecting spondylitis: a systematic review and meta-analysis.
    Yin Y; Liu X; Yang X; Guo J; Wang Q; Chen L
    Spine J; 2018 Dec; 18(12):2323-2332. PubMed ID: 30121323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
    Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can ¹⁸F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis.
    Chen YM; Pan XF; Tong LJ; Shi YP; Chen T
    Nucl Med Commun; 2011 Nov; 32(11):1005-10. PubMed ID: 21886014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
    Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
    Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Utility of Whole Body
    Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
    Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.